Bank of America Corporation »

Acrivon Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $50k 10k 4.92
2023-09-30 $89k 9.3k 9.56
2023-06-30 $99k 7.6k 12.96
2023-03-31 $74k 5.9k 12.69